Aleph Farms

Executive Summary

Aleph Farms is a pioneering Israeli cellular agriculture company that produces cultivated meat using proprietary scaffold-based technology. Founded in 2020, the company has raised over $150 million to develop whole-cut steaks and other animal products from stem cells without serum. By leveraging 3D bioreactors and serum-free media, Aleph Farms aims to address sustainability, food security, and animal welfare challenges. The company is in the commercial stage, having secured regulatory approvals in Singapore and partnerships in Switzerland and the Middle East, and is now scaling production for broader market entry. Despite the cultivated meat industry facing regulatory and cost hurdles, Aleph Farms' strong intellectual property and strategic alliances position it for near-term commercialization. The company's focus on premium cuts and its robust pipeline of products could capture significant market share in the alternative protein sector. With increasing consumer demand for sustainable protein and supportive regulatory frameworks in several countries, Aleph Farms is well-poised to be a leader in the cultivated meat space. However, key risks include high production costs, scalability, and the pace of regulatory approvals in major markets such as the US and EU.

Upcoming Catalysts (preview)

• Q3 2026Regulatory approval for sale of cultivated beef in Israel70% success
• Q2 2026Series D funding round to scale production capacity80% success
• Q4 2026Commercial launch of cultivated steak in a high-end restaurant partnership65% success